Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile

BioArctic Sweden

View original content:https://www.prnewswire.co.uk/news-releases/lecanemab-data-presented-at-ctad-on-early-initiation-and-long-term-treatment-suggest-increased-patient-benefit-with-maintained-safety-profile-302292627.html